Dr. Olivia Tournay Flatto is the President of The Pershing Square Foundation. She leads the Foundation’s efforts to deliver social impact by promoting exceptional leaders and innovative ideas in the areas of health and medicine, economic development, social justice, education, and the arts. In 2013, Dr. Tournay Flatto co-founded the Pershing Square Sohn Cancer Research Alliance. She continues to lead the implementation of its mission to enable the pursuit of the most innovative and advanced cancer research by facilitating collaborations between science and business.
Dr. Tournay Flatto spent a decade as President of the Emerald Foundation, an independently funded medical research foundation based in New York City and was the Director of External Affairs at the New York Stem Cell Foundation. She received her Ph.D. in Molecular Biology and Genetics from the University of Pennsylvania and completed her research at both the Wistar Institute in Philadelphia and the Sloan-Kettering Institute in New York City.
Dr. Tournay Flatto serves on boards of The Pershing Square Foundation, the Paris Opera and Ballet and the Institute of International Education. She was recognized by the French Government with the titles of “Chevalier de l’Ordre National du Merite” and “Chevalier de l’Ordre des Arts et des Lettres”.